APP and Alzheimer disease: For example, in an Aβ-accumulation AD model, synaptic mitochondria showed decreased mitochondrial respiration and enzymatic activity, accompanied by increased oxidative stress and compromised Ca2+ handling capacity in early phases of disease progression, when non-synaptic mitochondria showed no signs of impairment [127], similarly to APP transgenic rodent models [190].